Medtronic (MDT)

Discover Medtronic PLC (MDT) as a high-probability breakout stock with strong technicals, consolidation, and low-risk entry points for momentum traders.

Its stock has been languishing for a while, but management is working to get back on the growth track.

If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.

These top dividend stocks are steadily marching toward the throne room.

A longtime leader in financial services tops the list.

Medtronic PLC (MDT) is a top dividend stock with a 3.15% yield, steady growth, and strong profitability, making it a reliable choice for income-focused investors.

Spoiler: Your money wouldn't have grown much, but it might grow much faster in the years to come.

These stocks have high yields and reliable businesses, and they appear to be on sale.

This stock may reward patient investors in the long run.

Koninklijke Philips N.V. (AMS:PHIA), commonly known as Philips, is one of the most storied companies in the history of European industry. Founded in 1891 in Eindhoven, Netherlands, Philips has evolved from a modest light bulb manufacturer into a global leader in health technology and medical innovation. Its transformation

If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.

The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.

These S&P 500 dividend stocks have fallen by up to 33% and are best buys now.

The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans.

The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.

The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.

MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.

The company is also restructuring with the hopes of saving $400 million in expenses.